Volume 14

January-March 2022​

Review on anti diabetic drug - glibenclamide and their new formulation approches

Manu Chauhan, Ashish Kumar Varma

Abstract: 
Diabetes is a disease that occurs when your blood sugar or glucose level was not into the normal blood sugar or glucose level. Various drugs uses in the Treatment of Diabetes Type-2 and act by lower your blood sugar in a variety of ways. Sulphonylureas were discovered by Auguste Loubatières as the first pharmacological family of oral anti-diabetic drugs (OADs) is a kind of oral medication that works to regulate blood sugar levels in people with type 2 diabetes by stimulating insulin synthesis in the pancreas, which increases the efficacy of insulin in the body are typically divided into two generations (1st Generation and 2nd Generation). Glibenclamide, commonly known as Glyburide, is a kind of 2nd generation Sulphonylureas used in the treatment of type 2 diabetes mellitus. The creation of a novel formulation including both chemicals provides significant efficiency and compliance benefits, as well as operating as a multi-target medication system. The enhancement of the solublity and formulate Enhanced formulation like Transdermal patches, Inhalers, Misopourous silica.

Keywords: Diabetes, Glibenclamide, Formulation.